Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT00000538
First received: October 27, 1999
Last updated: August 11, 2014
Last verified: August 2014
  Purpose

To evaluate the effects of carefully controlled diets on lipoproteins and clotting factors in different demographic groups.


Condition Intervention Phase
Cardiovascular Diseases
Coronary Disease
Coronary Heart Disease Risk Reduction
Heart Diseases
Hyperlipoproteinemia
Myocardial Ischemia
Thrombosis
Behavioral: diet, fat-restricted
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by University of North Carolina, Chapel Hill:

Enrollment: 189
Study Start Date: September 1992
Study Completion Date: May 1995
Primary Completion Date: May 1995 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Men and women with low HDL and/or high triglyceride levels and/or high insulin levels.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000538

Sponsors and Collaborators
University of North Carolina, Chapel Hill
Investigators
Investigator: Patricia Elmer University of Minnesota - Clinical and Translational Science Institute
Investigator: Henry Ginsberg Columbia University
Investigator: Penny Kris-Etherton Penn State University
Investigator: Paul Roheim Louisiana State University Medical Center
  More Information

Publications:

Responsible Party: University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT00000538     History of Changes
Other Study ID Numbers: 81, U01HL049644
Study First Received: October 27, 1999
Last Updated: August 11, 2014
Health Authority: United States: Federal Government
United States: Institutional Review Board

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Thrombosis
Myocardial Ischemia
Coronary Artery Disease
Coronary Disease
Hyperlipoproteinemias
Embolism and Thrombosis
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on October 01, 2014